MedPath

Sebela Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

FDA:14

Drug Approvals

Naftin

Approval Date
Dec 12, 2023
FDA

Pramosone

Approval Date
Dec 6, 2023
FDA

PEXEVA

Approval Date
Aug 31, 2023
FDA

Analpram HC

Approval Date
Dec 20, 2022
FDA

LOTRONEX

Approval Date
May 3, 2019
FDA

Naftin

Approval Date
Dec 21, 2018
FDA

Pramosone

Approval Date
Dec 18, 2018
FDA

Motofen

Approval Date
Dec 14, 2018
FDA

Analpram HC

Approval Date
Dec 15, 2017
FDA

Pramosone

Approval Date
Dec 15, 2017
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.